Ehealth, INC

Market Movers (8-K)

See all →
NASDAQ
eHealth, Inc. announced its second quarter 2026 financial results, reporting a 45% year-over-year revenue decline and a wider net loss, attributed to a strategic pivot towards member engagement and reduced marketing spend.
Worse than expected
NASDAQ
eHealth stockholders approved an amendment to the 2024 Equity Incentive Plan, authorizing an additional 1.3 million shares for issuance.
NASDAQ
eHealth, Inc. announced its first quarter 2026 financial results, showing improved Medicare segment profitability and operating expense reductions, with key unit economics showing year-over-year improvement.
NASDAQ
eHealth, Inc. announced that director Andrea C. Brimmer will not seek re-election and will step down from the Board at the upcoming 2026 Annual Meeting of Stockholders.
NASDAQ
eHealth, Inc. announced strong financial results for Q4 and FY2025, driven by record revenue and significant earnings growth, but provided lower guidance for fiscal year 2026.
Worse than expected
NASDAQ
eHealth, Inc. announced a new $125 million asset-based revolving credit facility, repaying prior debt and enhancing financial flexibility for strategic growth.
Capital raise

Quarterly Earnings (10-Q)

See all →
NASDAQ
eHealth, Inc. disclosed a substantial decline in revenue and a widening net loss for the second quarter of 2026, driven by reduced marketing spend and lower approved members.
Worse than expected
NASDAQ
eHealth, Inc. reported an improved net loss for the third quarter and first nine months of 2025, driven by cost reductions and higher net adjustment revenue, despite declines in total approved members across key segments.
Capital raise
Delay expected
NASDAQ
eHealth, Inc. reported a decrease in Q2 2025 revenue but an improved net loss, alongside a planned CEO transition and ongoing legal proceedings.
NASDAQ
eHealth, Inc. announces a strong first quarter in 2025, fueled by significant growth in Medicare Advantage enrollments and improved cash flow.
Better than expected
NASDAQ
eHealth, Inc.'s third quarter 2024 results show a revenue decrease of 10% year-over-year, driven by a decline in commission revenue, despite growth in Medicare Advantage enrollments and a shift towards fee-based business models.
Worse than expected
NASDAQ
eHealth Inc. reported a complex second quarter with a slight revenue dip but significant growth in its Medicare segment, driven by strategic operational enhancements and market dynamics.
Worse than expected

Annual Reports (10-K)

NASDAQ
eHealth, Inc. posted a significant increase in net income and operating income for 2025, driven by higher commission revenue and improved Medicare product lifetime values, despite a decrease in total approved members and overall estimated membership.
Capital raise
NASDAQ
eHealth, Inc.'s 2024 10-K filing reveals a surge in Medicare enrollment and revenue, driven by market disruptions and strategic operational improvements.
Better than expected
Capital raise
NASDAQ
eHealth, Inc.'s 2023 10-K filing outlines the company's financial results, strategic initiatives, and risk factors, highlighting a return to growth and ongoing transformation efforts.
Better than expected

Insider Trading (Form 4)

See all →
NASDAQ
Derrick A Duke, Chief Executive Officer and a Director of eHealth, Inc., reported a transaction in 24,350 shares of common stock on August 4, 2026.
NASDAQ
John Joseph Dolan, Chief Financial Officer of eHealth, Inc., reported a transaction in 465 shares of common stock on July 10, 2026.
NASDAQ
Gavin G. Galimi, SVP, General Counsel & Secr. of eHealth, Inc., reported a transaction in 841 shares of common stock on July 10, 2026.
NASDAQ
Michelle Marie Barbeau, Chief Revenue Officer of eHealth, Inc., reported a transaction in 323 shares of common stock on July 10, 2026.
NASDAQ
Chief Revenue Officer Michelle Barbeau disposed of 4,311 shares of eHealth, Inc. to satisfy tax withholding obligations.
NASDAQ
Ehealth, Inc. Chief Financial Officer John Joseph Dolan acquired 1,500 shares of common stock and had shares withheld for tax obligations on May 10, 2026.

Proxy Statements (Def-14A)

See all →
NASDAQ
eHealth, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect directors, ratify auditor appointment, and approve an equity incentive plan amendment.
NASDAQ
eHealth, Inc. is requesting shareholder approval to increase its equity incentive plan by 1.5 million shares, citing strong 2024 financial performance, a return to profitability, and the need to attract and retain talent, including a new CEO, in a dynamic Medicare market.
Capital raise
Better than expected
NASDAQ
eHealth, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
eHealth is asking stockholders to approve an amendment to its 2024 Equity Incentive Plan to increase the maximum number of shares available for issuance by 1,500,000.
NASDAQ
eHealth, Inc. issues a supplement to its proxy statement to correct a typographical error in the Amended and Restated 2020 Employee Stock Purchase Plan (ESPP) regarding the maximum number of issuable shares.
NASDAQ
eHealth is asking stockholders to approve a new equity incentive plan to replace the expiring 2014 plan, aiming to support the company's strategy for sustainable profitable growth and cash flow generation.
Better than expected

Schedule 13G - Passive Investments

See all →
NASDAQ
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting beneficial ownership of 7.21% of eHealth, Inc. common stock as of June 30, 2026.
NASDAQ
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.52% in eHealth, Inc. common stock as of March 31, 2026.
NASDAQ
8 Knots Management and affiliated entities have filed a Schedule 13G, indicating they no longer beneficially own more than 5% of eHealth, Inc. common stock.
NASDAQ
Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, reported a 5.76% beneficial ownership stake in EHEALTH, INC. as of September 30, 2025.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a 4.99% beneficial ownership in eHealth Inc. common stock as of September 30, 2025.
NASDAQ
Goldman Sachs Group and its subsidiary have updated their beneficial ownership in EHEALTH, INC., reporting a 2.5% stake.